CareLit CareLitFachliteratur für Gesundheitsberufe
CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie

Chemovirotherapy – Improving the clinical outcome of advanced pancreatic adenocarcinoma by combining the oncolytic vaccinia virus GLV-1h68 with the dual chemotherapy nab-Paclitaxel + gemcitabine

E Binz, S Berchtold, C Geisler, I Smirnow, N Malek, U Lauer · Zeitschrift für Gastroenterologie · Ausgabe 08/2015

DOI 10.1055/s-0035-1559091

Bibliografische Angaben

Nachweis in CareLit

Autor:innenE Binz, S Berchtold, C Geisler, I Smirnow, N Malek, U Lauer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben

Kernaussage aus der Literatur

Abstract-Vorschau

Background: Oncolytic viruses have proven their therapeutic potential against a variety of different tumor entities both in vitro and in vivo. Their ability to selectively infect and lyse tumor cells, while sparing healthy tissues, makes them a favorable agent in specific tumor treatment. The collected evidence suggests that only in combination with already established forms of treatment their true therapeutic poten…

Zitieren

Zitierempfehlung

E Binz, S Berchtold, C Geisler, I Smirnow, N Malek, U Lauer (2015) Chemovirotherapy – Improving the clinical outcome of advanced pancreatic adenocarcinoma by combining the oncolytic vaccinia virus GLV-1h68 with the dual chemotherapy nab-Paclitaxel + gemcitabine. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0035-1559091

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur